A surveillance program in New Zealand found no link between meningococcal B immunisation and the subsequent development of HSP. Here.

In a series of patients with fever without localising signs under three years old, introduction of pneumococcal immunisation eliminated this as an aetiology, with urinary tract infection being the most common cause.  Here.

Using data from the Millenium Cohort Study, children who do not receive primary immunisations are less likely to go on to get MMR.  Here.

The antibody titres against Hib and MenC wane into the second year of life; a Hib-MenC-TT immunisation at 12-15 months boosted these levels in a phase III trial conducted in the UK and Poland.  Here.

In Uruguay, universal varicella immunisation at 12 months with 90% uptake has resulted in an 81% reduction in hospital admissions for varicella complications. Here.

In 6364 Japanese children having measles immunisation, 501 had a temperature of 37.5 C or higher in the week after, for whom the seroconversion rate was 76.6%, compared to 95.2% controls.  Here.

In a case control study of 98 children with autism spectrum disorder, 52 with developmental problems but no autism and 90 with normal development, no relationship was found with measles antibody levels and autistic symptoms. Here.

Perspective: Roderick, Ramanan and Finn look at the evidence for universal varicella vaccination in the UK.  Here.

Leading article: Elliman and Bedford review the negative impact of poor MMR uptake on the campaign to eliminate measles.  Here.

A BPSU survey of serious complications of chickenpox revealed a variety of complications in 0.82/100,000 children per year, mostly in previously healthy children.  Here.